Who
attends.

80

Senior delegates

30

Invited organisations

2

Days · The Savoy

14

Curated sessions

Discovery leadership

Chief Scientific Officers, Head of Drug Discovery, R&D Portfolio leads

CMC leadership

VP and SVP CMC, Head of Process Development, Global Biologics Operations

Regulatory strategy

Global Regulatory Affairs leads, Submission Directors, RA VPs

Clinical operations

Phase I–III Programme Directors, CMO and Medical Directors

Commercial development

BD leads, Licensing heads, Portfolio Strategy Directors

Enabling technology

Informatics, AI/ML in drug discovery, digital research platforms

AstraZeneca

GSK

Roche

Novartis

Sanofi

Bayer

Boehringer Ingelheim

Merck KGaA

Novo Nordisk

Lundbeck

UCB

Galapagos

Argenx

BioNTech

Evotec

Pfizer

Eli Lilly

Merck & Co.

J&J

Bristol Myers Squibb

AbbVie

Gilead

Amgen

Vertex

Regeneron

Moderna

Genentech

Takeda

Daiichi Sankyo

Astellas